Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 4Sarcoidosis, Pulmonary 1Primary Ovarian Insufficiency 1Polycystic Ovary Syndrome 1Peripheral Nervous System Diseases 1Pentoxifylline, Cisplatin, Nephrotoxixcity 1Pancreatitis, Alcoholic 1Pancreatitis 1Pain 1Neoplasms 1Mucositis 1Lymphedema 1Long-term Adverse Effects of Radiotherapy for Pelvic Cancer 1Head and Neck Neoplasms 1HIV Infections 1Gliosarcoma 1Glioblastoma 1Fibrosis 1Erectile Dysfunction 1Colorectal Neoplasms 1Central Nervous System Neoplasms 1Cachexia 1Breast Neoplasms, Male 1Brain Neoplasms 1Acquired Immunodeficiency Syndrome 1

Interventions

Doxorubicin 15Zidovudine 12Vincristine 11Bleomycin 10Interferon alpha-2 6Cyclophosphamide 5tecogalan 4sargramostim 4Methotrexate 4Liposomes 4Leucovorin 4Filgrastim 4Etoposide 4Dexamethasone 4Cytarabine 4Fluorouracil 3interferon alfa-n1 2Valganciclovir 2Tumor Necrosis Factor-alpha 2Thalidomide 2Rituximab 2Ritonavir 2Nivolumab 2Mitoxantrone 2Isotretinoin 2Interleukin-2 2Electrocoagulation 2Didanosine 2Allopurinol 2ziconotide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Acquired Immunodeficiency Syndrome × Pentoxifylline × Clear all
NCT00000646 2021-11-02

Pentoxifylline (Trental) as a Modulator of Tumor Necrosis Factor and of HIV Replication in Patients With AIDS

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 1 Completed
54 enrolled

Acquired Immunodeficiency Syndrome, Cachexia, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡